Get the Stockscreener App
2.42
3.20%
-0.08
Pre-market:
2.52
0.10
+4.13%
Oncology Institute Inc stock is traded at $2.42, with a volume of 678.83K.
It is down -3.20% in the last 24 hours and down -6.92% over the past month.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.
See More
Previous Close:
$2.50
Open:
$2.53
24h Volume:
678.83K
Relative Volume:
0.45
Market Cap:
$244.49M
Revenue:
$361.07M
Net Income/Loss:
$-71.54M
P/E Ratio:
-3.0633
EPS:
-0.79
Net Cash Flow:
$-47.97M
1W Performance:
-0.82%
1M Performance:
-6.92%
6M Performance:
+709.64%
1Y Performance:
+407.44%
1-Day Range:
$2.405
$2.5688
1-Week Range:
$2.40
$2.64
52-Week Range:
$0.1253
$3.50
Oncology Institute Inc Stock (TOI) Company Profile
Name
Oncology Institute Inc
Sector
Industry
Phone
562-735-3226
Address
18000 STUDEBAKER RD, CERRITOS
Compare TOI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TOI
Oncology Institute Inc
|
2.42 | 244.49M | 361.07M | -71.54M | -47.97M | -0.79 |
|
HCA
Hca Healthcare Inc
|
378.44 | 87.79B | 71.59B | 5.78B | 4.95B | 22.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
27.55 | 16.81B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
THC
Tenet Healthcare Corp
|
171.40 | 14.54B | 20.52B | 1.46B | 1.41B | 15.12 |
|
EHC
Encompass Health Corp
|
117.75 | 12.02B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
182.56 | 11.13B | 16.08B | 1.20B | 1.06B | 17.82 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-15-25 | Initiated | BTIG Research | Buy |
| Feb-26-24 | Resumed | Jefferies | Buy |
| Sep-14-22 | Initiated | Guggenheim | Buy |
| Aug-15-22 | Initiated | Jefferies | Buy |
Oncology Institute Inc Stock (TOI) Latest News
Ratios Uncovered: Breaking Down Oncology Institute Inc (TOI)’s Trailing Twelve Months Metrics - DWinneX
The Oncology Institute, Inc.'s (NASDAQ:TOI) market cap dropped US$28m last week; individual investors who hold 50% were hit as were institutions - simplywall.st
Jane Street Group LLC Has $39,000 Holdings in The Oncology Institute, Inc. (NASDAQ:TOI) - Defense World
Oncology Institute (TOI) Launches $50M Common Stock Offering | T - GuruFocus
The Oncology Institute (TOI) Plans $50 Million Stock Offering - GuruFocus
Oncology Institute Files $50 Million Shelf - MarketScreener
Oncology Institute Files For Stock Shelf Of Upto $50 Million - marketscreener.com
Oncology institute director Brad Hively sells $5.67m in stock By Investing.com - Investing.com India
Oncology institute director Brad Hively sells $5.67m in stock - Investing.com
The Oncology Institute, Inc. (NASDAQ:TOI) Sees Significant Growth in Short Interest - Defense World
Cancer clinical trials bring hope to patients in the Louisville, Kentucky, region - Norton Healthcare
The Oncology Institute joins Russell 2000 and 3000 indexes By Investing.com - Investing.com South Africa
The Oncology Institute (TOI) Set to Join Russell 2000 and 3000 i - GuruFocus
The Oncology Institute joins Russell 2000 and 3000 indexes - Investing.com
The Oncology Institute (TOI) Set to Join Russell 2000 and 3000 in 2025 | TOI Stock News - GuruFocus
The Oncology Institute, Inc. to Join Russell 2000® and Russell 3000® Indexes After 2025 Reconstitution - Nasdaq
The Oncology Institute set to join the Russell 2000® and Russell 3000® Indexes - The Manila Times
Major Market Milestone: The Oncology Institute Secures Spot in Both Russell 2000 and 3000 Indexes - Stock Titan
Oncology Institute (NASDAQ:TOI) Trading Up 2.9% – Time to Buy? - Defense World
Oncology Institute Explores PIPE Financing Opportunity - MSN
Oncology Institute And 2 Other Promising Penny Stocks To Watch - Yahoo Finance
Oncology Institute Gains 17%, Insider Trades Reap Benefit - simplywall.st
BTIG Research Begins Coverage on Oncology Institute (NASDAQ:TOI) - Defense World
The Oncology Institute, Inc. (NASDAQ:TOI) Q1 2025 Earnings Call Transcript - Insider Monkey
BTIG Initiates Coverage on Oncology Institute (TOI) with Enthusi - GuruFocus
Oncology Institute’s Earnings Call: Strong Start to 2025 - TipRanks
Oncology Institute Narrows Q1 Loss, Reaffirms 2025 Outlook On Capitation And Pharmacy Growth - Nasdaq
BTIG sets $7 price target on The Oncology Institute stock By Investing.com - Investing.com Nigeria
BTIG Initiates Oncology Institute at Buy With $7 Price Target - marketscreener.com
BTIG sets $7 price target on The Oncology Institute stock - Investing.com
BTIG Initiates Coverage on Oncology Institute (TOI) with Enthusiastic Outlook | TOI Stock News - GuruFocus
The Oncology Institute’s Strong Q1 2025 Performance - TipRanks
Earnings call transcript: Oncology Institute Q1 2025 results show revenue growth By Investing.com - Investing.com South Africa
The Oncology Institute (TOI) Reports Q1 Earnings and Revenue Inc - GuruFocus
Earnings call transcript: Oncology Institute Q1 2025 results show revenue growth - Investing.com Australia
Oncology Institute Q1 2025 Earnings Call Transcript - MarketBeat
The Oncology Institute, Inc. Reports Strong Q1 2025 Financial Results and Strategic Growth Initiatives - Nasdaq
The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer - The Manila Times
The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year ... - Bluefield Daily Telegraph
The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance - GlobeNewswire
The Oncology Institute Taps Former Cigna National Oncology Director to Scale Value-Based Care Model - Stock Titan
The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor Conference - The Manila Times
The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional ... - Eagle-Tribune
Leading Value-Based Oncology Group TOI Executives to Share Growth Strategy at B. Riley Conference - Stock Titan
Oncology Institute reports annual meeting outcomes By Investing.com - Investing.com Nigeria
The Oncology Institute to Present at Upcoming ASCO Annual - GlobeNewswire
Oncology Institute Holds Annual Stockholders Meeting - TipRanks
Oncology Institute reports annual meeting outcomes - Investing.com
Oncology Institute (TOI) Highlights Benefits of High-Value Cance - GuruFocus
Oncology Institute (TOI) Highlights Benefits of High-Value Cancer Care Model | TOI Stock News - GuruFocus
The Oncology Institute to Present at Upcoming ASCO Annual Meeting on High-Value Cancer Care Model Outcomes Showing Cost Savings and Lower Hospitalization Rates - marketscreener.com
Oncology Institute Inc Stock (TOI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Oncology Institute Inc Stock (TOI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| M33 Growth I L.P. | Director |
Jun 05 '25 |
Sale |
3.05 |
76,324 |
232,788 |
1,272,724 |
| Hively Brad | Director |
Jun 03 '25 |
Option Exercise |
0.90 |
1,867,605 |
1,682,524 |
2,579,638 |
| Hively Brad | Director |
Jun 03 '25 |
Sale |
2.87 |
1,976,137 |
5,672,106 |
603,501 |
0.23%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):